Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana

Identifieur interne : 000545 ( Main/Exploration ); précédent : 000544; suivant : 000546

Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana

Auteurs : Fred Stephen Sarfo [Ghana] ; Adetayo Kasim [Royaume-Uni] ; Richard Phillips [Ghana] ; Anna Maria Geretti [Royaume-Uni] ; David R. Chadwick [Royaume-Uni]

Source :

RBID : Pascal:14-0264029

Descripteurs français

English descriptors

Abstract

Objectives: To observe the long term response to first-line antiretroviral therapy (ART) in HIV and hepatitis B virus (HBV) co-infected patients in Ghana and explore predictors of poor clinical outcomes. Methods: Retrospective cohort study of hepatitis B surface antigen (HBsAg) positive and negative patients receiving predominantly NNRTI-based ART with lamivudine plus either zidovudine or stavudine for up to seven years. Cox proportional hazards and Kaplan Meier survival analyses compared clinical outcomes and identified baseline characteristics predictive of poor outcomes. A mixed effects model compared changes in CD4 counts. Results: A total of 299 HBsAg-positive and 1869 HBsAg-negative patients started ART between 2004 and 2008. Over a median 35 months of follow-up, HBsAg-positive patients were more likely to die or default care than HBsAg-negative patients, aHR 1.36 (95% CI, 1.03-1.80). HBsAg-positive patients were also more likely to develop Grade 3/4 hepatotoxicity than HBsAg-negative patients, HR 1.99 (1.16-3.40) on survival analysis. There was no significant difference in CD4 responses between HBsAg-positive and HBsAg-negative patients. Conclusions: HBsAg-positive patients are at significantly increased risk of adverse clinical outcomes after starting ART. Further studies are warranted to evaluate whether these risks remain now that tenofovir is becoming routinely available in Ghana.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana</title>
<author>
<name sortKey="Sarfo, Fred Stephen" sort="Sarfo, Fred Stephen" uniqKey="Sarfo F" first="Fred Stephen" last="Sarfo">Fred Stephen Sarfo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<wicri:noRegion>Komfo Anokye Teaching Hospital</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Kwame Nkrumah University of Science and Technology</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<wicri:noRegion>Kwame Nkrumah University of Science and Technology</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kasim, Adetayo" sort="Kasim, Adetayo" uniqKey="Kasim A" first="Adetayo" last="Kasim">Adetayo Kasim</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Wolfson Research Institute for Health and Wellbeing, Durham University</s1>
<s2>Stockton-on-Tees TS17 6BH</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Stockton-on-Tees TS17 6BH</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<wicri:noRegion>Komfo Anokye Teaching Hospital</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Kwame Nkrumah University of Science and Technology</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<wicri:noRegion>Kwame Nkrumah University of Science and Technology</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Geretti, Anna Maria" sort="Geretti, Anna Maria" uniqKey="Geretti A" first="Anna Maria" last="Geretti">Anna Maria Geretti</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Institute of Global Health, University of Liverpool</s1>
<s2>L69 7BE</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>L69 7BE</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chadwick, David R" sort="Chadwick, David R" uniqKey="Chadwick D" first="David R." last="Chadwick">David R. Chadwick</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>The James Cook University Hospital</s1>
<s2>Middlesbrough, TS4 3BW</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>The James Cook University Hospital</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">14-0264029</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0264029 INIST</idno>
<idno type="RBID">Pascal:14-0264029</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000001</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000127</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000004</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000004</idno>
<idno type="wicri:doubleKey">0163-4453:2014:Sarfo F:long:term:responses</idno>
<idno type="wicri:Area/Main/Merge">000546</idno>
<idno type="wicri:Area/Main/Curation">000545</idno>
<idno type="wicri:Area/Main/Exploration">000545</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana</title>
<author>
<name sortKey="Sarfo, Fred Stephen" sort="Sarfo, Fred Stephen" uniqKey="Sarfo F" first="Fred Stephen" last="Sarfo">Fred Stephen Sarfo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<wicri:noRegion>Komfo Anokye Teaching Hospital</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Kwame Nkrumah University of Science and Technology</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<wicri:noRegion>Kwame Nkrumah University of Science and Technology</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kasim, Adetayo" sort="Kasim, Adetayo" uniqKey="Kasim A" first="Adetayo" last="Kasim">Adetayo Kasim</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Wolfson Research Institute for Health and Wellbeing, Durham University</s1>
<s2>Stockton-on-Tees TS17 6BH</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Stockton-on-Tees TS17 6BH</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<wicri:noRegion>Komfo Anokye Teaching Hospital</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Kwame Nkrumah University of Science and Technology</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<wicri:noRegion>Kwame Nkrumah University of Science and Technology</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Geretti, Anna Maria" sort="Geretti, Anna Maria" uniqKey="Geretti A" first="Anna Maria" last="Geretti">Anna Maria Geretti</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Institute of Global Health, University of Liverpool</s1>
<s2>L69 7BE</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>L69 7BE</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chadwick, David R" sort="Chadwick, David R" uniqKey="Chadwick D" first="David R." last="Chadwick">David R. Chadwick</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>The James Cook University Hospital</s1>
<s2>Middlesbrough, TS4 3BW</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>The James Cook University Hospital</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">The Journal of infection</title>
<title level="j" type="abbreviated">J. infect.</title>
<idno type="ISSN">0163-4453</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">The Journal of infection</title>
<title level="j" type="abbreviated">J. infect.</title>
<idno type="ISSN">0163-4453</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>AIDS</term>
<term>Antiretroviral agent</term>
<term>Antiviral</term>
<term>Chemotherapy</term>
<term>Ghana</term>
<term>Human immunodeficiency virus</term>
<term>Long term</term>
<term>Viral hepatitis B</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>SIDA</term>
<term>Hépatite virale B</term>
<term>Antiviral</term>
<term>Chimiothérapie</term>
<term>Long terme</term>
<term>Antirétroviral</term>
<term>Virus immunodéficience humaine</term>
<term>Ghana</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Ghana</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Objectives: To observe the long term response to first-line antiretroviral therapy (ART) in HIV and hepatitis B virus (HBV) co-infected patients in Ghana and explore predictors of poor clinical outcomes. Methods: Retrospective cohort study of hepatitis B surface antigen (HBsAg) positive and negative patients receiving predominantly NNRTI-based ART with lamivudine plus either zidovudine or stavudine for up to seven years. Cox proportional hazards and Kaplan Meier survival analyses compared clinical outcomes and identified baseline characteristics predictive of poor outcomes. A mixed effects model compared changes in CD4 counts. Results: A total of 299 HBsAg-positive and 1869 HBsAg-negative patients started ART between 2004 and 2008. Over a median 35 months of follow-up, HBsAg-positive patients were more likely to die or default care than HBsAg-negative patients, aHR 1.36 (95% CI, 1.03-1.80). HBsAg-positive patients were also more likely to develop Grade 3/4 hepatotoxicity than HBsAg-negative patients, HR 1.99 (1.16-3.40) on survival analysis. There was no significant difference in CD4 responses between HBsAg-positive and HBsAg-negative patients. Conclusions: HBsAg-positive patients are at significantly increased risk of adverse clinical outcomes after starting ART. Further studies are warranted to evaluate whether these risks remain now that tenofovir is becoming routinely available in Ghana.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Ghana</li>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<country name="Ghana">
<noRegion>
<name sortKey="Sarfo, Fred Stephen" sort="Sarfo, Fred Stephen" uniqKey="Sarfo F" first="Fred Stephen" last="Sarfo">Fred Stephen Sarfo</name>
</noRegion>
<name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name>
<name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name>
<name sortKey="Sarfo, Fred Stephen" sort="Sarfo, Fred Stephen" uniqKey="Sarfo F" first="Fred Stephen" last="Sarfo">Fred Stephen Sarfo</name>
</country>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Kasim, Adetayo" sort="Kasim, Adetayo" uniqKey="Kasim A" first="Adetayo" last="Kasim">Adetayo Kasim</name>
</noRegion>
<name sortKey="Chadwick, David R" sort="Chadwick, David R" uniqKey="Chadwick D" first="David R." last="Chadwick">David R. Chadwick</name>
<name sortKey="Geretti, Anna Maria" sort="Geretti, Anna Maria" uniqKey="Geretti A" first="Anna Maria" last="Geretti">Anna Maria Geretti</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000545 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000545 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:14-0264029
   |texte=   Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024